Clinical Trial Update: Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach [Phase 3]

View source ↗

Summary

This is a completed Phase 3 trial update (OPTimize NOW) evaluating a symptom-based dosing approach to optimize pharmacologic treatment for neonatal abstinence s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome

Snippet

Sponsor: HELP for NOWS Consortium | Conditions: Neonatal Opiate Withdrawal Syndrome | Phase 3 | Status: COMPLETED